University of Alabama
Birmingham, Alabama, 25294-0111, United States
Location contact
Stephanie Wallace, MD
SUB_INVESTIGATOR
Stephenie Wallace, MD
CONTACT
NCT Number: NCT06876324
This study applies Social Cognitive Theory to develop behavioral interventions promoting PrEP adherence. It seeks to adapt and test the enhanced HMP app for feasibility and acceptability among Black adolescents and young adults (AYAs) and adult supports.
Trial opening soon.
Get Notified14 year–21 year
All sexes
Interventional
Not applicable
Birmingham, Alabama, 25294-0111, United States
Stephanie Wallace, MD
SUB_INVESTIGATOR
Stephenie Wallace, MD
CONTACT
HIV pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV infections, reducing the risk by over 90%. However, adherence among AYAs remains suboptimal, with only 34% maintaining adherence at 48 weeks. Studies suggest that adult support can improve adherence in pediatric HIV treatment, but this approach has not been systematically evaluated for PrEP use in AYAs. Prior research indicates that Black AYAs and their families are open to incorporating adult support for PrEP adherence.
Given the success of mobile health (mHealth) interventions in promoting sexual health, this study aims to enhance the HealthMPowerment (HMP) app-an existing mHealth platform designed for HIV prevention-to facilitate dyadic communication between Black AYAs and trusted adult support persons.
The study addresses the high rates of HIV among Black adolescents and young adults (AYAs) in Alabama, where AYAs (ages 13-24) account for 31% of new HIV diagnoses, with Black gay and bisexual males, transgender individuals, and heterosexual young women being disproportionately affected. Nearly half of new infections occur in rural areas. The U.S. Department of Health and Human Services Ending the HIV Epidemic initiative prioritizes Alabama as a geographic hotspot, emphasizing the need for patient-centered interventions to reduce HIV incidence.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A mobile health app designed to facilitate increased PrEP use and adherence among AYAs
Time frame: 1 month, 3 months, and 6 months
The study evaluates an app's impact through post-intervention interviews, focusing on user experience, ethical concerns, and future usage intentions. It explores burden, satisfaction, attitudes, and how the app influences communication and adherence. Sekhon's Theoretical Framework of Acceptability will be utilized to measure this outcome.
Time frame: 1 month, 3 months, and 6 months
Communication between adolescents and young adults (AYA) and support person (i.e., Experience using chat features; Experience using forums). A modified version of Structured Assessment of FEasibility (SAFE) will be utilized to measure this outcome.
Time frame: 1 month, 3 months, and 6 months
This will be measured by analyzing the percent of dates with data entered into the medication tracker and correlating that data with reasons why participants did not take their medication (when applicable)
Time frame: 1 month, 3 months, and 6 months
This will be measured by comparing the amount of time (minutes) spent using distinct features of the app (e.g. forums, educational resources, avatars, side effect trackers, chat features)
Contact information is provided by the study sponsor or research team.
Samantha Hill, MD, MPH
CONTACT
Stephanie Wallace, MD, MPH
CONTACT
Emory University
Other
Adolescent SPEAKS Study: Integrating Supports to Promote PrEP for Black Adolescents Working With Apps
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07711366
Behavior, Cardiovascular Disease Prevention
Kitale, Trans Nzoia County, Kenya
View Trial DetailsNCT04955795
Acquired Immunodeficiency Syndrome, Alcohol Problem
Birmingham, Alabama, United States
View Trial DetailsNCT05608421
Behavior, Engagement, Patient
Baltimore, Maryland, United States
View Trial DetailsNCT04588883
ART, Acquired Immunodeficiency Syndrome
Maua, Meru County, Kenya
View Trial Details